Fibroid Uterine Embolization
Uroplasty neuromodulation expands patent portfolio Uroplasty, Inc., a medical device company that designs, manufactures and markets patented for the treatment of voiding dysfunctions, today announced the award of U.S. Patent No. 7,729,772 covers a method using a system of neuromodulation implantation in the treatment of urinary incontinence or tibial nerve stimulation neuromodulation. The …
Uterine Fibroid Embolization